This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID) | MicrobiomeTrials
← Back to trials NCT01306019
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID) Recruiting PHASE1, PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2012-09-25Est. Completion: 2032-12-31
Enrollment target: 40 participantsLocations National Institutes of Health Clinical Center, Bethesda, Maryland, United States Other microbiome trials you might be interested in X-linked Severe Combined Immunodeficiency X-SCID XSCID
Background:
X-linked severe combined immunodeficiency (XSCID) is a rare inherited disorder that affects the immune syst…
Bethesda, United States Completed Dec 31, 2034
Chronic Granulomatous Disease (CGD) X-Linked Severe Combined Immune Deficiency (XSCID) Leukocyte Adhesion Deficiency 1 (LAD) Graft Versus Host Disease (cGvHD)
This study will evaluate patients with abnormal immune function that results in recurrent or unusual infections or chron…
Bethesda, United States